BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2011
View Archived Issues
Safety data presented from clinical evaluation of BIBF-1120 in hepatocellular carcinoma
Read More
New qRT-PCR-based microRNA profiling technique serves as diagnostic tool in CTCL
Read More
Ardea Biosciences provides update on lesinurad development
Read More
Results presented from several clinical studies assessing zonisamide in partial epilepsy
Read More
Bristol-Myers Squibb describes new chemokine CCR2 receptor antagonists
Read More
Boehringer Ingelheim Pharma patents novel therapies for HIV
Read More
New nitric oxide donors claimed for diabetes-associated neuropathic pain
Read More
Phase I/II data presented on DAC-060 in nonmelanoma skin cancer
Read More
Novartis develops novel cyclin-dependent kinase inhibitors
Read More
New glycoprotein-Ig fusion proteins generated to elicit immunity against HCV
Read More
BioLineRx signs agreement with Tel Aviv University for BL-7050
Read More
Pharnext gathers funds for further development of Pleodrug for Charcot-Marie-Tooth disease
Read More
Novel recombinant proteins catalyze tRNA aminoacylation
Read More
Trophos completes enrollment in pivotal study of olesoxime
Read More
Pluristem's PLX cells show promise in preclinical studies
Read More
Repros Therapeutics presents phase II data on low-dose Proellex
Read More
FDA clears DelMar Pharmaceuticals' IND for phase I/II VAL-083 trial
Read More
Bristol-Myers Squibb acquires Amira Pharmaceuticals
Read More
FDA committee issues recommendation on rivaroxaban to prevent stroke and systemic embolism in AF
Read More
NeurogesX submits sNDA for Qutenza to FDA
Read More
Alchemia opens recruitment in phase II HA-irinotecan trial
Read More
Spherix combination treatment reduces VLDL and LDL in preclinical study
Read More
ME-143 enters clinical development
Read More
HUYA Bioscience partners with Chinese university
Read More
Enterologics completes acquisition of BioBalance
Read More